Potential Epigenetic Biomarkers for Prostate Cancer Screening

키워드

참고문헌 (32)

1. Chiam K, "Epigenetic biomarkers in prostate cancer: Current and future uses", Cancer Lett, 342, pp.248~256 (2014)[DOI]
2. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
3. James Eastham, "Prostate cancer screening", Investigative and Clinical Urology, 58(4), pp.217~219 (2017), 대한비뇨의학회[DOI]
4. Welch HG, "Overdiagnosis in cancer", J Natl Cancer Inst, 102, pp.605~613 (2010)[DOI]
5. Bae JM, "Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean", Epidemiol Health, 37, pp.e2015015~ (2015)[DOI]
6. Pinsky PF, "Prostate cancer screening - a perspective on the current state of the evidence", N Engl J Med, 376, pp.1285~1289 (2017)[DOI]
7. Stewart RW, "Screening for prostate cancer", Semin Oncol, 44, pp.47~56 (2017)[DOI]
8. Moyer VA, "Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement", Ann Intern Med, 157, pp.120~134 (2012)[DOI]
9. Loeb S, "Evidence-based versus personalized prostate cancer screening: using baseline prostate-specific antigen measurements to individualize screening", J Clin Oncol, 34, pp.2684~2686 (2016)[DOI]
10. Ruane-McAteer E, "Active surveillance for favorable-risk prostate cancer: Is there a greater psychological impact than previously thought? A systematic, mixed studies literature review", Psychooncology, 26, pp.1411~1421 (2017)[DOI]
11. Roehrborn CG, "Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia", Urology, 53, pp.581~589 (1999)[DOI]
12. Mundbjerg K, "Identifying aggressive prostate cancer foci using a DNA methylation classifier", Genome Biol, 18, pp.3~ (2017)[DOI]
13. Yegnasubramanian S, "Prostate cancer epigenetics and its clinical implications", Asian J Androl, 18, pp.549~558 (2016)[DOI]
14. 이윤재, "Is Prostate-Specific Antigen Effective for Population Screening of Prostate Cancer? A Systematic Review", Annals of Laboratory Medicine, 33(4), pp.233~241 (2013), 대한진단검사의학회
15. 이혜원, "60세 미만 한국인의 전립선암 선별에 있어 전립선특이항원속도의 유용성 및 새로운 절단치", Investigative and Clinical Urology, 49(2), pp.113~117 (2008), 대한비뇨의학회
16. pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng, "mL prostate specific antigen range", J Urol, 185, pp.1650~1655 (2011)[DOI]
17. Lee R, "A meta-analysis of the performance characteristics of the free prostate-specific antigen test", Urology, 67, pp.762~768 (2006)[DOI]
18. Wei JT, "Can urinary PCA3 supplement PSA in the early detection of prostate cancer", J Clin Oncol, 32, pp.4066~4072 (2014)[DOI]
19. Endzelins E, "Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review", Mol Cancer, 15, pp.41~ (2016)[DOI]
20. Shariat SF, "Tumor markers in prostate cancer I: blood-based markers", Acta Oncol, 50(Suppl 1), pp.61~75 (2011)
21. Bjartell A, "Tumour markers in prostate cancer II: diagnostic and prognostic cellular biomarkers", Acta Oncol, 50(Suppl 1), pp.76~84 (2011)[DOI]
22. Roobol MJ, "Tumour markers in prostate cancer III: biomarkers in urine", Acta Oncol, 50(Suppl 1), pp.85~89 (2011)[DOI]
23. Dmitriev AA, "Identification of novel epigenetic markers of prostate cancer by NotI-Microarray analysis", Dis Markers, 2015, pp.241301~ (2015)
24. Chinaranagari S, "Prostate cancer epigenome", Methods Mol Biol, 1238, pp.125~140 (2015)
25. Jeronimo C, "Epigenetics in prostate cancer: biologic and clinical relevance", Eur Urol, 60, pp.753~766 (2011)[DOI]
26. Kgatle MM, "Prostate cancer: epigenetic alterations, risk factors, and therapy", Prostate Cancer, 2016, pp.5653862~ (2016)
27. Yang M, "DNA methylation in promoter region as biomarkers in prostate cancer", Methods Mol Biol, 863, pp.67~109 (2012)
28. Geybels MS, "Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue", Prostate, 75, pp.1941~1950 (2015)[DOI]
29. Blute ML Jr, "The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications", Curr Opin Urol, 25, pp.83~88 (2015)[DOI]
30. Wu T, "Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis", Br J Cancer, 105, pp.65~73 (2011)[DOI]
31. Troyer DA, "Promise and challenge: markers of prostate cancer detection, diagnosis and prognosis", Dis Markers, 20, pp.117~128 (2004)[DOI]
32. Wu Y, "Epigenetics in breast and prostate cancer", Methods Mol Biol, 1238, pp.425~466 (2015)

관련 논문AI추천